<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <title>lymphomadebrief</title>
        <meta name="description" content="">
        <link rel="shortcut icon" type="image/png" href="L.D.png">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        <link rel="stylesheet" href="styles.css">
        <link href="https://fonts.googleapis.com/css?family=Montserrat:500&display=swap" rel="stylesheet">
        <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.2/css/all.min.css" />
        <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/slick-carousel/1.8.1/slick.min.js"/>
        <script defer src="script.js"></script>
    </head>
    <body>
        <div class="container">
            <div class="header">
                        <a class="contact" href="">Contact</a>
                        <a class="logo" href="index.html">Lymphoma Debrief</a> 

                    <div class="search">
                    </div>
                </div>
            <div class="nav">
                <li><a href="index.html">Home</a></li>
                <li><a href="system.html">Lyphmatic System</a></li>
                <li><a href="cell.html">B-cells and T-cells</a></li>
                <li><a href="what.html">What is Lymphoma?</a></li>               
                <li><a href="treat.html">Treatments</a></li>
                <li><a href="research.html">Research Summaries</a></li>
            </div>
            <div class="treatmenttitle">
            <h3>Treatment for Lymphoma</h3>
            </div>
            <div class="treatment">
                <div class="treatmentone">
                  <div class="treatmenttop">
                    <h5>Treatment for Indolent Non Hodgkins Lymphoma</h5>
                  </div>
                  <div class="modal-scroll">
                    <div class="modal-scrollobject">   
                  <div class="treatmentbottom">                                    <p>Rituximab: Monoclonal antibody (the cloning of a unqiue white blood cells)</p>
                                <br>
                                <p>Obinutuzmad: Anti-CD20 monoclonol antibody (used to acheieve B-cell (mutated cells) depletion)</p>
                                <br>
                                <p>Lenalidomide and Rituximab: Combination of a cancer drug used to slow the growth of cancer cells (lenalidomide) and monoclonal antibodies (rituximab) </p>
                                <br>
                                <p>Phosphatidylinostiol 3-Kinase (PI3K) Inhibitor: Blocks the PI3K pathway to slow down the growth of cancer</p>
                                <br>
                                <p>E2H2 inhibitor (tazemetostat): prevents the growth of tumor</p>
                                <br>
                                <p>Pallative raditation therapy: High energy rays are used to strink a cancer and slow it's growth</p>
                                <br>
                                <p>Radiolabeled Anti-CD20 monoclonal antibodies: radiolabeled antibodies that have a specific target</p>
                                <br>
                                <p>Chimeric antigen receptor (CAR) T-cell therapy: These receptors bind to cancer cells and kills them</p>
                                <br>
                                <p>Stem cell transplant: A transplant done to introduce healthier stem cells and replace the destroyed stem cells</p>
                              </div>
                            </div>
            </div>
        </div>
                <div class="treatmentone">
        <div class="treatmenttop">
          <h6>Treatment for Agressive Non Hodgkins Lymphoma</h6>
        </div>
        <div class="modal-scroll">
          <div class="modal-scrollobject">   
        <div class="treatmentbottom">                                    <p>Rituximab: Monoclonal antibody (the cloning of a unqiue white blood cells)</p>
          <p>Locanstiuximab testirine: antibody drug (CD-19) conjugate (antibody + chemically linked drug)</p>
          <br>
          <p>Tafiasitamab plus lenalidomide: anti - CD19 monoclonial antibody (treat B-cell malignancies)</p>
          <br>
          <p>Polatuzumab vedotin plus rituximab and bendamustine: antibody-drug conjugate targeting (D79b: a b-cell that has expressed 90% of B-cell mallignancies) plus an monoclonal antibody and a chemotherapy drug that prevents cancer cell growth </p>
          <br>
          <p>Chimeric antigen receptor (CAR) T-cell therapy: These receptors bind to cancer cells and kills them</p>
          <br>
          <p>Stem cell transplant: A transplant done to introduce healthier stem cells and replace the destroyed stem cells</p>
          <br>
          <p>Bone Marrow transplant: A transplant done to replace a bone marrow that isn't prodducing enough healthy blood cells. </p>
                    </div>
                  </div>
  </div>
        </div>
                  <div class="treatmentone">
                  <div class="treatmenttop">
                    <h5>Treatment for Hodgkins Lymphoma</h5>
                  </div>
                  <div class="modal-scroll">
                 <div class="modal-scrollobject">   
              <div class="treatmentbottom">
                <p>Pembrolizumab: A humanized monoclonal antibody that blacks PD-1 allowing t-cells to kill cancer cells.</p>
                <br>
                <p>Nivolumab: A human programmed death receptor-1 (PD-1) also known as a monoclonal antibody.</p>
                <p> &emsp; - PD-1 will bound to a protein called PD-L1 (which keeps the immune system from attacking nonharmful cells). This increases the t-cells ability to kill cancer cells.</p>
                <br>
                <p>Brentuximab vedotin: antibody-drug conjugate for certain CD-30 (Hodgkins lymphoma marker) lymphomas.</p>
                <br>
                <p>Brentuximab vedotin + nivolumab: antibody-drug conjugate for certain CD-30 (Hodgkins lymphoma marker) lymphomas + A human programmed death receptor-1 (PD-1) also known as a monoclonal antibody.</p>
                <br>
                <p>Chemotherapy regimen: Brentuximab, vedotin + doxorubicin (antibody-drug conjugate aganist CD-30), vinblastine (stops the growth of cancer cells), dacarbazine(stops the growth of cancer cells) )</p> 
                <br>
                <p>Radiation therapy: High doses of radiation used to kill cancer cells.</p>       
                <br>
                <p>Combination chemotherapy: The use of multiple chemotherapy drugs at one time (i.e. bleomycin, etoposide, and cisplatin).</p>                            
            </div>
          </div>
</div>
        </div>
            </div>
        </div>
        <footer class="footer">
          <div class="footername">
              <button onclick="topFunction()" id="myBtn" title="Go to top">Back to top</button>
              <p>Lymphoma Debrief</p>
              <p>Created in 2022.</p>
          </div>
      </footer>
    </body>
</html>